Document is current
Any future updates will be listed below
-
Authors
Chascsa, David Maxwell Hunter https://orcid.org/0000-0003-2972-6545
Lindor, Keith Douglas
- License Information
-
More Information
Article History
Received: 4 December 2019
Accepted: 5 January 2020
First Online: 22 January 2020
Compliance with ethical standards
:
: There was no financial support provided for the creation of this manuscript. Dr. Keith Lindor was an unpaid advisor for Intercept pharmaceuticals and Shire pharmaceuticals. Dr. David Chascsa has nothing to declare.
